Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
Facing increasing revenue pressures, the state expects to save $17 million per year from the move
Low blood glucose (sugar), or hypoglycemia, is rare with Ozempic and other GLP-1s when taken alone
Glaesner W, Vick AM, Millican R, Ellis B, Tschang SH, Tian Y, Bokvist K, Brenner M, Koester A, Porksen N, Etgen G, Bumol T (2010) Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
doi: 10.1016/j.schres.2024.07.039 139 JiRNZhangLLZhaoMFHeHFBaiWDuanRXet al
In conclusion this study demonstrates that iDPC delivers a controlled and predictable manufacturing process for the development of fixed dose combination DPI formulations and presents a viable new alternative to the antiquated gold standard manufacturing processes currently used across the industry